Xiaohong Lü

1.7k total citations
48 papers, 1.2k citations indexed

About

Xiaohong Lü is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaohong Lü has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Xiaohong Lü's work include Cancer-related Molecular Pathways (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (5 papers). Xiaohong Lü is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (5 papers). Xiaohong Lü collaborates with scholars based in China, United Kingdom and United States. Xiaohong Lü's co-authors include John Lunec, Qiang Lü, Zhaozhao Ding, David L. Kaplan, Fei Liao, Yuanjie Yu, David R. Newell, Julie Errington, Nicola J. Curtin and Andrew Pearson and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Oncogene.

In The Last Decade

Xiaohong Lü

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohong Lü China 23 640 231 201 156 116 48 1.2k
Jie Gao China 24 910 1.4× 296 1.3× 251 1.2× 164 1.1× 128 1.1× 90 1.7k
Zeng Fan China 17 609 1.0× 191 0.8× 278 1.4× 182 1.2× 87 0.8× 62 1.2k
Giulia Russo Italy 29 1.3k 2.0× 283 1.2× 326 1.6× 139 0.9× 152 1.3× 61 1.8k
Silvia Baldari Italy 18 603 0.9× 273 1.2× 242 1.2× 91 0.6× 103 0.9× 24 1.2k
Joshua J. Souchek United States 16 462 0.7× 245 1.1× 326 1.6× 117 0.8× 201 1.7× 22 1.0k
Annapina Russo Italy 29 1.2k 1.9× 275 1.2× 315 1.6× 139 0.9× 150 1.3× 50 1.7k
Sanam Sadreddini Iran 16 734 1.1× 366 1.6× 281 1.4× 150 1.0× 106 0.9× 25 1.4k
Wei Jing China 18 403 0.6× 235 1.0× 166 0.8× 86 0.6× 75 0.6× 32 854
Yuxiang Wang China 20 678 1.1× 299 1.3× 179 0.9× 61 0.4× 125 1.1× 83 1.4k
Sheng Zhou China 24 586 0.9× 239 1.0× 372 1.9× 60 0.4× 190 1.6× 46 1.1k

Countries citing papers authored by Xiaohong Lü

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Lü more than expected).

Fields of papers citing papers by Xiaohong Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Lü. The network helps show where Xiaohong Lü may publish in the future.

Co-authorship network of co-authors of Xiaohong Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Lü. A scholar is included among the top collaborators of Xiaohong Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Lü. Xiaohong Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Xiaohong, et al.. (2025). Decoding phillygenin’s dual attack on breast cancer: ferroptosis induction and immune evasion suppression. Journal of Molecular Histology. 56(4). 234–234.
2.
Gong, Sha, Guohui Li, Xiaohong Lü, et al.. (2022). An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial). Blood Cancer Journal. 12(11). 158–158. 21 indexed citations
3.
Lü, Xiaohong, Sha Gong, Nan Hu, et al.. (2021). Celastrol Exerts Cardioprotective Effect in Rheumatoid Arthritis by Inhibiting TLR2/HMGB1 Signaling Pathway-Mediated Autophagy. International Archives of Allergy and Immunology. 182(12). 1245–1254. 17 indexed citations
4.
Hu, Nan, Jing Zhang, Jing Wang, et al.. (2021). Biomarkers of joint metabolism and bone mineral density are associated with early knee osteoarthritis in premenopausal females. Clinical Rheumatology. 41(3). 819–829. 8 indexed citations
6.
Liao, Fei, et al.. (2020). Exosomes derived from T regulatory cells relieve inflammatory bowel disease by transferring miR‐195a‐3p. IUBMB Life. 72(12). 2591–2600. 37 indexed citations
8.
Sądej, Rafał, Xiaohong Lü, Vera Novitskaya, et al.. (2018). CD151 regulates expression of FGFR2 in breast cancer cells via PKC-dependent pathways. Journal of Cell Science. 131(21). 11 indexed citations
9.
Gao, Yujing, Xuehua Chen, Rongrong Xu, et al.. (2018). Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial–mesenchymal transition. Journal of Translational Medicine. 16(1). 38–38. 19 indexed citations
10.
Yao, Qing, Yi Yang, Xiaohong Lü, et al.. (2018). Lycium Barbarum Polysaccharides Improve Retinopathy in Diabetic Sprague‐Dawley Rats. Evidence-based Complementary and Alternative Medicine. 2018(1). 7943212–7943212. 22 indexed citations
11.
Lü, Xiaohong, Yuanjie Yu, & Shiyun Tan. (2017). p53 expression in patients with ulcerative colitis - associated with dysplasia and carcinoma: a systematic meta-analysis. BMC Gastroenterology. 17(1). 111–111. 21 indexed citations
12.
Zhao, Jie, Xiaohong Lü, Yong Wang, & Timothy Thatt Yang Tan. (2014). Surface-up constructed tandem-inverted bilayer cyclodextrins for enhanced enantioseparation and adsorption. Journal of Chromatography A. 1343. 101–108. 13 indexed citations
14.
Liao, Fei, Zirong Yang, Xiaohong Lü, Xufeng Guo, & Weiguo Dong. (2013). Sinomenine sensitizes gastric cancer cells to 5-fluorouracil in vitro and in vivo. Oncology Letters. 6(6). 1604–1610. 24 indexed citations
15.
Ahmed, Shafiq U., Christopher R. Coxon, Junfeng Liu, et al.. (2013). Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions. MedChemComm. 4(9). 1297–1297. 19 indexed citations
16.
Reiman, Anne, et al.. (2012). Gene expression and protein array studies of folliculin-regulated pathways.. Anticancer Research. 32(11). 4663–4670. 5 indexed citations
17.
Lü, Xiaohong, Wenbin Wei, Janine Fenton, et al.. (2011). Therapeutic Targeting the Loss of the Birt-Hogg-Dubé Suppressor Gene. Molecular Cancer Therapeutics. 10(1). 80–89. 15 indexed citations
18.
Lü, Xiaohong, Peter K. Vogt, Dale L. Boger, & John Lunec. (2008). Disruption of the MYC transcriptional function by a small-molecule antagonist of MYC/MAX dimerization. Oncology Reports. 19(3). 825–30. 33 indexed citations
19.
Logan, Ian R., Hesta McNeill, Susan Cook, et al.. (2007). Analysis of the MDM2 antagonist nutlin‐3 in human prostate cancer cells. The Prostate. 67(8). 900–906. 37 indexed citations
20.
Lü, Xiaohong & Guangsheng Li. (2000). Study of the mechanism of neurone apoptosis in rats from the chronic fluorosis. 19(2). 96–98. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026